TFS Capital’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-1,103
| Closed | -$158K | – | 792 |
|
|
2017
Q1 | $158K | Buy |
+1,103
| New | +$158K | 0.05% | 542 |
|
|
2016
Q2 | – | Sell |
-122
| Closed | -$14K | – | 1211 |
|
|
2016
Q1 | $14K | Sell |
122
-116
| -49% | -$13.3K | ﹤0.01% | 978 |
|
|
2015
Q4 | $45K | Sell |
238
-859
| -78% | -$162K | ﹤0.01% | 709 |
|
|
2015
Q3 | $187K | Buy |
+1,097
| New | +$187K | 0.02% | 749 |
|
|
2014
Q3 | – | Sell |
-289
| Closed | -$396K | – | 1243 |
|
|
2014
Q2 | $396K | Sell |
289
-350
| -55% | -$480K | 0.03% | 731 |
|
|
2014
Q1 | $887K | Buy |
+639
| New | +$887K | 0.06% | 509 |
|